Home > About Spectrum > News > Spring SADR Symposium Draws Crowds
Spectrum CTSA K12 graduate awarded
NCATS R03 grant
MAKING CATHETER EMBOLIZATION SAFER AND MORE PRECISE
NOVEMBER 2025

Stanford Assistant Professor Alexander Vezeridis, MD, PhD, a Spectrum CTSA K12 scholar from the 2020-2022 cohort, has received an NCATS R03 award on “Advancing catheter electrochemical impedance spectroscopy for precision medicine of embolotherapy.” The project aims to make catheter embolization safer, more precise, and ultimately less reliant on x-rays. By integrating sensing and feedback directly into the microcatheter, Dr. Vezeridis hopes to guide therapy delivery in real time—improving reproducibility, reducing radiation exposure for patients and healthcare teams, and expanding access to these procedures. The ultimate goal is clinical translation, bringing this technology from prototype to practical use in the interventional suite.
Dr. Vezeridis’ initial concept and prototype ideas took shape while he was performing a uterine fibroid embolization and saw that the radiation dose to the patient and the medical team was escalating quickly.
“That experience made it clear that we need smarter, data-driven, and safer systems for these procedures,” he explains. “Catheter embolization combines anatomy, physics, and creativity—and yet so much still depends on operator intuition. I wanted to make the process more quantitative, reproducible, and evidence based.”
Regarding his involvement in the K12 scholar program, Dr. Vezeridis has nothing but praise for the experience and refers to the program as “transformative.”
“The KL2 program provided the mentorship, structure, and protected time to bridge engineering and clinical interventional radiology,” he says. “It also introduced me to a remarkable network of talented colleagues across campus and to diverse research methodologies—including population health approaches—that now form a core part of my research program. Those experiences helped me learn how to build interdisciplinary teams, write successful grants, and translate ideas from benchtop prototypes to early clinical applications.”
Read more details about Dr. Vezeridis’ award here.